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ABSTRACT: Bioactive lipids derived from themetabolism of polyunsaturated fatty acids are importantmediators of the
inflammatory response. Labor per se is considered a sterile inflammatory process. Intra-amniotic inflammation (IAI)
due to microorganisms (i.e., intra-amniotic infection) or danger signals (i.e., sterile IAI) has been implicated in the
pathogenesis ofpreterm laborandclinical chorioamnionitis at term.Early andaccuratediagnosis ofmicrobial invasion
of the amniotic cavity (MIAC) requires analysis of amniotic fluid (AF). It is possible that IAI causedbymicroorganisms
is associatedwith a stereotypic lipidomicprofile, and that analysis ofAFmayhelp in the identificationof patientswith
this condition. To test this hypothesis, we analyzed the fatty acyl lipidome of AF by liquid chromatography—mass
spectrometry from patients in spontaneous labor at term and preterm gestations. We report that the AF concen-
trations of proinflammatory lipidmediators of the 5-lipoxygenase pathway are significantly higher inMIAC than
in cases of sterile IAI. These results suggest that the concentrations of 5-lipoxygenase metabolites of arachidonic
acid, 5-hydroxyeicosatetraenoic acid, and leukotrieneB4 inparticular could serve aspotentialbiomarkers ofMIAC.
This finding could have important implications for the rapid identification of patientswhomay benefit from anti-
microbial treatment.—Maddipati, K. R., Romero, R., Chaiworapongsa ,T., Chaemsaithong, P., Zhou, S.-L., Xu, Z.,
Tarca, A. L., Kusanovic, J. P., Gomez, R., Chaiyasit, N., Honn, K. V. Lipidomic analysis of patients with microbial
invasionof theamniotic cavity revealsup-regulationof leukotrieneB4.FASEBJ.30, 3296–3307 (2016).www.fasebj.org
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Intra-amniotic inflammation (IAI) causedbymicroorganisms
(i.e., intra-amniotic infection) or by danger signals [i.e.,
sterile IAI (SI)] is often subclinical (1–3) and is amajor cause
of maternal and neonatal morbidity (4–7). The differential
diagnosis of these 2 conditions requires analysis of the
amniotic fluid (AF) and has clinical implications, because
treatment of infection requires the administration of
antimicrobial agents. Early treatment has beneficial ef-
fects for both mother and neonate (8–10).
Bioactive lipids derived from the metabolism of poly-
unsaturated fatty acids (PUFAs), such as arachidonic
acid, play a dual role in promoting and dampening the in-
flammatory response to injury because of microorganisms,
such as bacteria, viruses, or sterile insults (11–19). Prosta-
glandins (20–33) and arachidonate lipoxygenase products,
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such as leukotriene B4 (LTB4) (34–36), are also involved in
parturition at term.
The objective of this study was to determine whether
the fatty acyl lipidome of AF analyzed by an unbiased
liquid chromatography–mass spectometry (LC-MS) ap-
proach differs among patients with spontaneous labor at
term (TLB), clinical chorioamnionitis at term (TCC), and
preterm labor (PTL), as well as among subgroups of pa-
tients stratified according to the status of AFmicrobiology
and inflammation.
MATERIALS AND METHODS
Study design and population
A retrospective cross-sectional study was conducted by search-
ing the clinical database and Bank of Biologic Samples of the
Detroit Medical Center, Wayne State University, and the Peri-
natology Research Branch of the Eunice Kennedy ShriverNational
Institute of Child Health and Human Development, National
Institutes of Health, Department of Health and Human Services
(NICHD/NIH/DHHS; Bethesda, MD, USA). The inclusion cri-
teria were: 1) singleton gestation; 2) transabdominal amnio-
centesis performed between 20 and 42 wk of gestation, before
the rupture of the chorioamniotic membranes; 3) absence of
chromosomal or structural fetal anomalies; and 4) sufficient AF
available for lipidomic studies. Women from the following
groups with singleton pregnancies who had AF samples
obtained by transabdominal amniocentesis were included: 1)
women at term gestation with TLB (TLB; n = 35); 2) women
with PTL and IAI [PTL-IAI; n = 25; divided into 2 subgroups:
those without detectable microbial invasion of the amniotic
cavity (MIAC) (PTL-IAI-noMIAC; n = 15) and those with de-
monstrable MIAC (PTL-IAI-MIAC; or intra-amniotic infection
or microbe-associated IAI; n = 10)]; 3) women with a sono-
graphic short cervix (SCX; n = 28); and 4) women with clinical
chorioamnionitis at term (TCC; n = 24). Patients with TCCwere
further subdivided into those with IAI (TCC-IAI-MIAC; n = 12),
thosewith SI (TCC-SI;n=8), and thosewith noAIA (NI) (TCC-NI;
n = 4). Themicrobial status of the amniotic cavity was determined
by both broad-range PCR and cultivation techniques in patients
with TCC, whereas only the cultivation approach was used in
patients with PTL and SCX. The fatty acyl lipidome of human AF
was analyzed by LC-MS.
All patients provided written informed consent before the
collection of AF samples. The collection and utilization of the
sampleswere approved by theHuman InvestigationCommittee
of the participating institutions and the Institutional Review
Boards of the participating institutions where the patients re-
ceived care. Many of these samples had been used in previous
studies of the biology of cytokines and inflammatory mediators
in intra-amniotic infection/inflammation, PTL (5, 37), and TCC
(38–43).
Clinical definitions
Spontaneous term labor was defined as the presence of regular
uterine contractionswith a frequency of at least 1 every 10min and
cervical changes after 37 wk of gestation leading to delivery of a
term neonate. Clinical chorioamnionitis was diagnosed by the
presenceofmaternal fever (temperature,.37.8°C)accompaniedby
2 or more of the following criteria: 1) maternal tachycardia (heart
rate .100 beats/min); 2) uterine tenderness; 3) foul-smelling
AF; 4) fetal tachycardia (heart rate.160 beats/min); and 5) ma-
ternal leukocytosis (leukocyte count .15,000 cells/mm3)
(40). PTL was diagnosed by the presence of at least 2 regular
uterine contractions every 10 min associated with cervical
changes in patients with a gestational age between 20 and 36/
37 wk. An SCX was defined as a cervical length #25 mm be-
tween 16 and 32wk of gestation. IAI was diagnosedwhen the
AF IL-6 concentrationwas$2.6 ng/ml, determined by ELISA
(37, 44, 45). MIAC was defined according to the results of AF
culture and PCR coupled with electrospray ionization mass
spectrometry (PCR/ESI-MS; IbisTechnology;Athogen,Carlsbad,
CA, USA). Based on the results of AF cultures and/or
PCR/ESI-MS, as well as AF concentrations of IL-6, patients
were classified as having NI (IL-6 , 2.6 ng/ml), intra-
amniotic infection (combination of MIAC and IAI), or SI (IAI
without detectable bacteria; an elevated AF IL-6 concentra-
tion without evidence of bacteria detected by either cultiva-
tion or molecular microbiologic methods).
Sonographic assessment of the cervix
Transvaginal ultrasound examinations were performed with
commercially available ultrasound systems (Acuson Sequoia;
Siemens Medical Systems, Mountain View, CA, USA; Voluson
730 Expert or Voluson E8, GEHealthcare, Milwaukee,WI, USA)
equipped with endovaginal transducers with frequency ranges
of 5–7.5 and 5–9 MHz, respectively. Sonographic examinations
of the cervixwere performed according to a published technique
(46, 47).
Sample collection
AF samples were obtained by transabdominal amniocentesis
performed for evaluation of the microbial and inflammatory
status of the amniotic cavity in patients presenting with PTL or
TCC, whereas patients approaching term underwent an amnio-
centesis for assessment of fetal lung maturity. The results of mi-
crobiology and inflammatory status of the AF were used by
obstetricians and neonatologists in the management of mothers
and neonates in terms of treatment with antibiotics. Women at
term in labor consisted of those who were admitted for sus-
pected PTL because of uncertain dates and who had an am-
niocentesis for the assessment of fetal lung maturity. The
criteria for considering whether these patients were at term in
labor were derived retrospectively as: 1) spontaneous labor; 2)
delivery within 24 h of amniocentesis; 3) analysis of AF con-
sistent with fetal lung maturity; 4) birth weight .2500 g; 5)
absence of respiratory distress syndrome or other complica-
tions of prematurity; and 6) findings in physical examination of
the newborn by a pediatrician consistent with a term neonate.
Samples of AF were transported to the laboratory in a sterile
capped syringe and cultured for aerobic/anaerobic bacteria
and genital mycoplasmas. White blood cell (WBC) count (48),
glucose concentration (49), and Gram stain (50) were also
performed shortly after collection. The results of these tests
were used for clinicalmanagement, in contrast to the results of
AF IL-6 concentration, which were used only for research
purposes. AF that was not needed for clinical assessment was
centrifuged at 1300 g for 10 min at 4°C, and the supernatant
was stored at 270°C.
Detection of microorganisms with
molecular methods
In addition to standard cultivation techniques that included
aerobic and anaerobic bacteria, as well as genital mycoplasmas,
theAFofpatientswith clinical chorioamnionitiswasanalyzedby
using broad-range real-time PCR/ESI-MS (Ibis Technology;
Athogen) (37). In brief, DNAwas extracted from 300 ml of AF by
using a method that combines bead-beating cell lysis with a
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magnetic bead-based extraction method (51, 52). The extracted
DNA was amplified by the previously described broad bacteria
and Candida (BAC) detection assay according to the manufac-
turer’s instructions. PCR/ESI-MS can identify 3400 bacteria and
40 Candida spp., which are represented in the platform’s signa-
ture database (53, 54).
After PCR amplification, 30 ml aliquots of each PCR product
were desalted and analyzed via ESI-MS. The presence of
microorganisms was determined by signal processing and
triangulation analysis of all base composition signatures
obtained from each sample and compared to a database. The
sensitivity (limit of detection) of the assay for the detection of
bacteria in blood is, on average, 100 CFU/ml (95% CI, 6–600
CFU/ml). A comparison of detection limits between blood
and AF showed that the assays have comparable detection
limits (100 CFU/ml).
Determination of IL-6 in AF
The concentrations of IL-6 in AFwere determined by sensitive
and specific enzyme immunoassays obtained from R&D
Systems (Minneapolis,MN,USA). The initial assay validation
was performed in our laboratory before this study was con-
ducted. The immunoassay uses the quantitative sandwich
enzyme immunoassay technique, and the concentrations
were determined by interpolation from the standard curves.
The inter- and intra-assay coefficients of variation for IL-6
were 8.7 and 4.6%, respectively. The sensitivity of the assay for
IL-6 was 0.09 pg/ml.
Sample preparation and LC-MS analysis
Fatty acyl lipids from AF samples were extracted and
analyzed by LC-MS essentially as described earlier (55,
56). However, the LC-MS analysis was focused on the
5-lipoxygenase pathway metabolites of arachidonic acid
that included 5-hydroxyeicosatetraenoic acid (5-HETE),
5-oxoeicosatetraenoic acid (5-oxoETE), leukotrieneB4 (LTB4), 5(S),12
(S)-dihydroxyeicosatetraenoic acid [5(S),12(S)-diHETE], and lipoxin
B4 (LXB4). Octadeuterated-15(S)-hydroxyeicosatetraenoic acid (15-
HETE-d8)andtetradeuteratedleukotrieneB4 (LTB4-d4)wereused
as internal standards to monitor recovery and for quantitation.
Under standardized conditions of LC-MS quantitation, the
detection limits for the eicosanoids are 1–2 pg on the column
and the limit of quantitation is 5 pgat a signal-to-noise ratio of 3.
Because the sample volume used was 200 ml, these conditions
translate to an assay sensitivity of 0.03 nM for an average
molecular weight of 330 of the detected eicosanoids.
Statistical analysis
For demographics data analysis, the Kolmogorov-Smirnov test
was used to test whether the distribution of continuous variables
was normal. Comparisons of continuous data were analyzed by
using the Kruskal-Wallis and Mann-Whitney U tests. Statistical
analysis was performed with SPSS software (version 19; IBM
Corp., Armonk, NY, USA). A value of P, 0.05 indicated statis-
tical significance.
For any detectable lipid analyte in a subject group, a zero
value observed in any sample was replaced with one-half
the average detection limit of the LC-MSmethod used for the
eicosanoids (i.e., 0.015 nM). This method ensured that in-
formation from all sampleswas used in the statistical analysis
and that the fold change between groups was finite for each
analyte. A Wilcoxon test, which does not rely on any distri-
butional assumptions about the data, was used for all pair-
wise group comparisons. The significance of thePvalue of the
Wilcoxon test is independent of the choice of the threshold
concentration used to replace the values below the quanti-
tation limits of the assay.
Aparametric alternative to theWilcoxon testwas also applied
by using a Student’s t test for analyteswith concentrations above
the sensitivity of the assay in all samples, or using censored re-
gression otherwise. In the presence of a perfect separation be-
tween groups, the maximum likelihood estimation involved in
censored regression couldnot be applied; hence, a Student’s t test
was used instead.
To account for multiple testing, the P values obtained for all
analytes in a given group comparison were adjusted to control
the false-discovery rate (FDR) (57). A threshold of 10% on the
FDRwas used to infer significance. All analyses were performed
in the R statistical language and environment, version 3.0 (http://
www.r-project.org), with the censReg R package for the censored
regression analysis (58).
RESULTS
Clinical characteristics of the
study populations
The demographic and clinical characteristics of
patients in this study are displayed in Table 1. Desig-
nation of IAI was based on an AF IL-6 concentra-
tion $2.6 ng/ml. All patients with TCC, with the
exception of those without intra-amniotic infection/
inflammation (TCC-NI group) had a median AF IL-6
concentration $2.6 ng/ml.
TABLE 1. Clinical and obstetric characteristics of women with TLB, TCC, SCX, and PTL-IAI
Characteristic TLB (n = 35) TCC (n = 24) Pa SCX (n = 28) PTL-IAI (n = 25) Pb
Gestational age at
amniocentesis (wk)
39 (38–40.2) 40.0 (39.2–40.6) 0.075 26.6 (25.0–28.6) 31.1 (28.5–33.4) ,0.001
AF IL-6 (ng/ml) 1.1 (0.8–1.7)c 10.4 (3.0–18.3) ,0.001 ND 21.5 (6.0–140.1) ND
AF glucose (mg/dl) 10.0 (8.5–12.0)d 9 (9–9) 0.068 30.0 (26–35)e 15.0 (5.0–32.5) 0.002
AF WBC (cell/mm3) 7.0 (5.0–25.0) 22.5 (5.0–656.3) 0.048 0 (0–2) 6.0 (2.5–257.5) ,0.001
Gestational age at
delivery (wk)
39.0 (38.0–40.2) 40.0 (39.2–40.6) 0.067 39.3 (38.8–40.1) 32.1 (29.9–34.0) ,0.001
Birth weight (g) 3250 (3100–3730) 3625 (3385–3790) 0.100 3148 (2986–3510) 2000 (1300–2575) ,0.001
Values are expressed as median and interquartile range (in parentheses). ND, not determined. aRepresents TLB vs. TCC. bRepresents SCX
vs. PTL-IAI. cDetectable in only 11 of the 35 samples. dData not available in 6 cases. eData not available in 1 case.
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Patients with an SCX (a control group for patients in
PTL) had a significantly shorter gestational age at amnio-
centesis and lower AF inflammatory response (higher AF
glucose and lower AF WBC counts) than those who had
PTL and IAI (PTL-IAI group). All patients with an SCX
delivered at term.
Table 2 displays the clinical characteristics of the
patients with TCC and PTL. There was no significant
difference in gestational age at amniocentesis and de-
livery among the subgroups of patients with TCC. The
median AF WBC count and IL-6 concentrations were
significantly higher in patients with TCC who had IAI
(TCC-SI and TCC-IAI-MIAC) than in those without
intra-amniotic infection/inflammation (TCC-NI). The
most common microorganism isolated from the am-
niotic cavity in patients at term with clinical chorioamnio-
nitis and intra-amniotic infection (TCC-IAI-MIAC group)
was Ureaplasma urealyticum (4/12 cases). Patients with
PTL-IAI-MIAC had a significantly higher median
AF IL-6 concentration and WBC count, but lower AF
glucose and gestational age at delivery than those
with IAI and no MIAC (PTL-IAI-noMIAC). The most
common microorganism identified in AF of patients
with PTL-IAI-MIAC was Ureaplasma urealyticum (5/10
cases; Table 2).
LC-MS analysis of arachidonic acid
metabolites in human AF
Metabolism of arachidonic acid by the 5-lipoxygenase
pathway results in several inflammatory and resolution
mediators (Fig. 1). The LC-MS method included multi-
ple reaction monitoring (MRM) transitions for the
5-lipoxygenase metabolites of linoleic acid, eicosa-
pentaenoic acid, and docosahexaenoic acid, in addition
to arachidonic acid. Each detected fatty acyl lipid was
positively identified by a combination of matching
HPLC retention time with the authentic standard and
the unique MRM transition (56). Although hydroxy
fatty acids derived from all of the above-listed PUFAs
were detectable, only the concentrations of arachidonic
acid metabolites including 5-HETE, 5-oxoETE, LTB4,
5(S),12(S)-diHETE, and LXB4 were significantly dif-
ferent between patient groups (P, 0.05 and FDR, 0.1)
and are shown in the tables and figures. Eicosanoids
derived from the cyclooxygenase pathway were also
detected in these samples by LC-MS. However, there
was no statistically significant difference in the con-
centrations of these metabolites between any of the
study groups (Supplemental Table S1).
Inflammatory lipid mediators in patients
with TCC
AF inflammatory lipid mediators derived from the me-
tabolism of arachidonic acid by 5-lipoxygenase path-
way had significantly higher concentrations in patients
with TCC-IAI-MIAC than in those with TCC-SI or
no TCC-NI (Fig. 2 and Table 3). This difference was
more marked for 5-HETE and LTB4 (Table 4). The T
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concentrations of AF IL-6 were not significantly dif-
ferent between TCC-IAI-MIAC and TCC-SI. LTB4
concentrations alone could separate patients belonging
to these 2 groups (P, 1.63 1023; Table 4). As expected,
both 5-HETE and LTB4 are significantly higher in pa-
tientswith TCCwithTCC-IAI-MIAC, compared to those
at TLB. However, such differences were not observed
between patients in the TCC-SI group and those with
spontaneous TLB (Fig. 2 and Tables 3 and 4).
AF inflammatory lipid mediators in PTL-IAI
Arachidonate 5-lipoxygenase metabolites were also de-
tectable in the AF of patients with PTL-IAI, regardless of
the presence of microorganisms in the amniotic cavity
(PTL-IAI-noMIACor PTL-IAI-MIAC) (Fig. 3 andTable 3).
To account for any specific differences related to ges-
tational age, AF samples from patients with SCX who
delivered at term were used as controls. Except for
LTB4, all other 5-lipoxygenase metabolites, when de-
tectable, were present at a higher concentration in pa-
tients with PTL in the PTL-IAI-noMIAC group than in
those with a gestational age–matched SCX (Table 3).
Similar to observations at term, concentrations of both
5-HETE and LTB4 were significantly higher in the
subset of patients with PTL-IAI-MIAC than in those
with PTL-IAI-noMIAC (P, 6.93 1023 and 4.03 1023,
respectively; Table 4). Whereas LXB4 was virtually
undetectable in the PTL-IAI-noMIAC group, 3 of the 10
samples in the PTL-IAI-MIAC group showed the me-
tabolite; however, the difference was not statistically
significant (Fig. 3). AF IL-6 concentration was signifi-
cantly higher in the PTL-IAI-MIAC group than in the
PTL-IAI-MIAC group (P , 0.04; Fig. 3 and Table 4).
AF inflammatory lipid mediators and MIAC
Regardless of gestational age (term or preterm), 5-lip-
oxygenase metabolites of arachidonic acid, especially
5-HETE and LTB4, had higher concentrations in the AF
of patients in the IAI-MIAC group than in those in the
IAI-noMIAC group (P , 1.9 3 1024 and 1.9 3 1025, re-
spectively) (Fig. 4andTables 3and4). The concentrationof
the double lipoxygenase metabolite, 5(S),12(S)-diHETE
was also significantly higher in patients in the IAI-MIAC
group than in those in the IAI-noMIAC group (P, 7.93
1024). 5-OxoETE, on the other hand, although showing a
statistically significant difference between IAI-MIAC and
IAI-noMIAC, was not detectable in most samples, and
there was no difference in the median concentration.
DISCUSSION
Principal findings of the study
First, the AF concentrations of metabolites of arachidonic
acid by the 5-lipoxygenase pathway were significantly
higher in the IAI-MIAC group than in those in the IAI-
noMIAC group; second, although the inflammatory cy-
tokine IL-6 in AF is a biomarker of IAI (irrespective of
the cause; i.e., SI or IAI–MIAC), LTB4 and 5-HETE were
increased in the subset in which microorganisms were de-
tected by cultivation ormolecularmethods; therefore, LTB4
and 5-HETE could serve as biomarkers for the presence of
microorganisms in the amniotic cavity. This finding is
important because the detection of microorganisms takes
time (days when cultivation techniques are used), which
delays the clinical decision-making process, whereas, a
streamlined LC-MSmethod for the analysis of these lipid
Figure 1. Metabolites of arachidonic acid in the 5-lipoxygenase pathway that showed signiﬁcant concentration differences in
human AF in the patient groups of the study.
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mediators can be accomplished in less than 1 hour.
Chemical methods can also be developed for the rapid
detection of these metabolites at the bedside.
AF lipid mediators of IAI without demonstrable
microorganisms in the amniotic cavity
Spontaneous parturition at term has been likened to an
inflammatory process by virtue of leukocyte infiltration of
gestational tissues (59–62), as well as elevated concentra-
tionsof inflammatory cytokines, suchas IL-1b (63, 64), IL-6
(60, 65, 66), TNF-a (67, 68), IL-8 (69, 70), and monocyte
chemotactic protein (MCP)-1 (72, 73). Induction of cyclo-
oxygenase (COX)-2 expression in placental membranes in
response to elevated cytokines also results in enhanced
biosynthesis of proinflammatory prostaglandins, such as
PGE2 and PGF2a in AF, even in the absence of IAI, and
precedes the onset of labor (21, 23, 24, 26, 27, 31, 32, 73, 74).
Our recent MS-based lipidomic analysis of human AF at
term confirmed that significantly higher concentrations of
prostaglandins were observed in patients with spontane-
ous TLB than in those not in labor (55). TCC is an intra-
amniotic inflammatory state that can present with clinical
signs such as maternal fever and foul-smelling AF (40).
Similarly, PTL is associated with IAI. Biochemically,
IAI is characterized by a high concentration of IL-6
($2.6 ng/ml) in theAF (5, 6, 37, 44, 75). As expected, the
median concentration of AF IL-6 in patients in all
groups (TCC-SI, TCC-IAI-MIAC, PTL-IAI-noMiac, and
PTL-IAI-MIAC), other than in women in TLB and those
with TCC without IAI, was significantly higher (me-
dian: 8.4–96 ng/ml; Table 3).
Despite the demonstrable IAI process (neutrophil in-
filtration and elevated cytokines in AF) in patients with
TCC (including TCC-SI and TCC-IAI-MIAC), the con-
centrations of inflammatory prostaglandins such as PGE2
were unexpectedly not significantly different among the
TCC-IAI-MIAC, TCC-SI, and TLB groups (Supplemental
Table S1). LTB4, the chemotactic leukotriene of the 5-
lipoxygenase pathway, was virtually undetectable in
the PTL-IAI-noMIAC, TCC-SI, or TCC-NI groups and
similar to the TLB group (Fig. 2 and Tables 3 and 4).
Therefore, SI associated with clinical chorioamnionitis
is not reflected in higher concentrations of prostaglan-
dins and other inflammatory lipid mediators normally
increased in AF during spontaneous labor, suggesting
that PTL in the absence of intra-amniotic infection/
inflammation may not be mediated by prostaglandins.
AF lipid mediators of IAI with demonstrable
microorganisms in the amniotic cavity
In contrast to the comparable concentrationsofmost of the
eicosanoids between TLB and TCC without detectable
Figure 2. Arachidonate 5-lipoxygenase metabolites in human AF at term in spontaneous labor. Concentrations of the lipid
mediators from patients at term in labor without clinical chorioamnionitis (TLB) compared to those with clinical chorioamnionitis
but no intra-amniotic infection or inﬂammation (TCC-NI), SI (TCC-SI), and MIAC as well as IAI (TCC-IAI-MIAC). Results of
assessments are shown. Cross bars: median concentration. *P , 0.05; **P , 0.005.
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microorganisms in the amniotic cavity (TCC-NI and
TCC-SI) (unpublished results), higher concentrations
of inflammatory lipid mediators derived from the
5-lipoxygenase pathway were observed in the AF of
patients with microbial-associated IAI (TCC-IAI-MIAC
and PTL-IAI-MIAC) compared to those without IAI or
with IAI but without demonstrable microorganisms
(TCC-NI, TCC-SI, and PTL-IAI-noMIAC) (Table 3). Of
these, 5-HETE, 5-oxoETE, and LTB4 are well-known
lipid mediators involved in host defense against in-
fection (76–80).
The neutrophil chemotactic lipid mediator LTB4 can
elicit an innate immune response against microbial and
fungal pathogens (81) and is detected at significantly
higher concentrations in TCC-IAI-MIAC and PTL-IAI-
MIAC, compared to TCC-NI, TCC-SI, and PTL-IAI-
noMIAC (undetectable) (Table 3). It is noteworthy that the
levels of LTB4 in MIAC (median concentration 4.5 nM;
Table 3) are well above the saturating concentrations
for the high-affinity LTB4 receptor BLT1 [KD = 0.15 nM
(82)], suggesting that our findings have functional
consequences.
In addition to LTB4, another neutrophil chemotactic
lipid mediator of the 5-lipoxygenase pathway detected
primarily in TCC-IAI-MIAC is 5-oxoETE (Fig. 3 and
Table 3,). 5-OxoETE induces receptor-mediated inflam-
matory response in eosinophils and neutrophils in con-
cert with inflammatory cytokines, such as granulocyte
macrophage–colony-stimulating factor andTNF-a (80, 83,
84). 5-HETE is the precursor of 5-oxoETE, and the reaction
is catalyzed by 5-hydroxyeicosanoid dehydrogenase, an
enzyme present in a wide variety of cells, such as mono-
cytes, dendritic cells, platelets, endothelial cells, epithelial
cells, and airway smooth muscle cells in addition to neu-
trophils (80, 85). Despite the significant concentrations of
5-HETEinAFofTCC-NI,TCC-SI, andTLBgroups (median:
6–14 nM), 5-oxoETE was not detectable in these groups
compared to one-third of TCC-IAI-MIAC samples with
detectable levels (Table 3), suggesting an alternate route
of inflammatory lipidmediator generation in response to
microbial infection. It should be noted that 5-oxoETE is
highly reactive and further metabolized by leukotriene
C4 (LTC4) synthase to 5-oxo-7-glutathionyl-8,11,14-
eicosatrienoic acid (FOG)7, an analog and isobar of LTC4
(86, 87). (FOG7), also exhibits neutrophil and eosinophil
chemotaxis, but without an increase in intracellular cal-
cium levels, thereby extending the biologic activity of
5-oxoETE (86). It is possible that the low levels of
5-oxoETE detected are due to the results of its further
metabolism or other chemical modifications that arise
from its inherent reactivity. Further analysis of AF for
FOG7 will be helpful in extending the understanding of
the role of the 5-lipoxygenase pathway in MIAC.
LXB4 is an anti-inflammatory/proresolution lipid me-
diator that follows acute inflammatory events and pre-
vents further recruitment of leukocytes (88–91). AF LXB4
concentration appeared to be higher in patients with
chorioamnionitis at termandmicrobial-associated IAI than
in those with no intra-amniotic infection/inflammation or
SI (median: 1.5 nM for TCC-IAI-MIAC vs. undetectable in
TCC-NI andTCC-SI;P, 0.07 and0.22, respectively). LXB4T
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was present in some PTL-IAI-MIAC cases (3/10) but was
undetectable in most of the PTL-IAI-noMIAC cases (14/
15). Therefore, the 5-lipoxygenase pathway is functional in
each of the 5 patient groups (term gestation with sponta-
neous labor, TCC, and PTL, with or without MIAC in the
latter 2); however, only the AF of patients with microbial-
associated IAI has detectable inflammatory lipid media-
tors, LTB4 and 5-oxoETE, as well as the resolution
mediator, LXB4. Since biosynthesis of LXB4 involves
the intermediacy of LTA4 in the 5-lipoxygenase path-
way, its absence is also reflected in the absence of
microbe-driven inflammation.
The detection of bacteria in the amniotic cavity is
typically determined by traditional culture methods.
Although the culture method remains the gold stan-
dard, the time needed for such diagnosis (days) and
the fact that many microorganisms responsible for
intra-amniotic infection are nonculturable presents a
formidable clinical challenge and can delay treatment.
However, recently developed molecular methods
based on PCR combined with MS that reduce the de-
tection time to ;8 h offer great promise (37, 53). The
near-exclusive detection of LTB4 in AF with MIAC, re-
gardless of gestational age (Fig. 4), offers yet another
molecular technique for the rapid detection of intra-
amniotic infection. TheMS-based assay for LTB4 can be
very fast (with the use of ion mobility spectrometry, for
example), significantly reducing the time to diagnosis
TABLE 4. Statistical signiﬁcance of the difference in 5-lipoxygenase metabolites of arachidonic acid and IL-6 between patient groups as
determined by the Wilcoxon test
Group 5-HETE 5-OxoETE LTB4 5(S), 12(S)-diHETE LXB4 IL-6
TCC-NI vs. TCC-IAI-MIAC 0.02* 0.23 4.1 3 1023# 4.4 3 1023# 0.07 1.1 3 1023#
TCC-SI vs. TCC-IAI-MIAC 0.03* 0.29 1.6 3 1023# 0.02* 0.22 0.57
TCC-NI vs. TCC-SI 0.37 NA 0.22 0.68 0.22 4.0 3 1023#
PTL-IAI-noMIAC vs. PTL-IAI-MIAC 6.9 3 1023* 0.15 4.0 3 1023# 0.08 NA 0.04
IAI-noMIAC vs. IAI-MIAC 1.9 3 1024# 0.02* 1.9 3 1025# 7.9 3 1024# 0.05 5.5 3 1023*
*P , 0.05, #P , 0.005. NA, not applicable.
Figure 3. Arachidonate 5-lipoxygenase metabolites in human AF of patients in the PTL-IAI group. Lipid mediator concentrations
of AF with similar gestational age, but without IAI (SCX), compared with those in the PTL-IAI group, but without microbial
infection (PTL-IAI-noMIAC) or with microbial invasion of the amniotic cavity (PTL-IAI-MIAC). Results of assessments are shown.
Cross bars: median concentration. *P , 0.05, **P , 0.005.
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of intra-amniotic infection. Since LTB4 represents a host
inflammatory response to microbial infection, this bio-
marker could reflect the presence of bacteria in patients
with IAI associated with sustained bacterial or viral in-
fection or both, and not to the results of any potential
sample contamination of AF from the vaginal micro-
biome. Concerns of contamination in transvaginal re-
trieval make transabdominal amniocentesis the gold
standard to collect AF for the detection of MIAC. How-
ever,measurement of LTB4 and 5-HETE in transvaginally
retrieved AF has the potential to alleviate such concerns
and obviate the need for significantly more invasive
procedures for the detection of MIAC.
CONCLUSIONS
HumanAF contains significantly higher concentrations of
the inflammatory lipid mediator LTB4 as well as 5-HETE,
in caseswithmicrobial-associated IAI compared to SI. IL-6
concentrations inAF cannot distinguish between IAI,with
and without detectable microorganisms in the amniotic
cavity (IAI-noMIAC vs. IAI-MIAC), whereas LTB4 mea-
surements have the potential to serve as a biomarker of
microbial presence. LC-MS quantification of these me-
tabolites offers a rapid, efficient, and definitivemethod for
the identification of intra-amniotic infection.
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